Status:

ACTIVE_NOT_RECRUITING

Minnesota RETAIN Phase 2 (Sub-study)

Lead Sponsor:

Mayo Clinic

Collaborating Sponsors:

Minnesota Department of Employment and Economic Development

Minnesota Department of Labor and Industry

Conditions:

Injuries Related Work

Illness Related Work

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

MN RETAIN Phase 2 Sub-study is a non-randomized trial to evaluate the impact of RETAIN program expansion and services on workforce retention and reduction of future workplace disability in the state o...

Eligibility Criteria

Inclusion

  • Inclusion Criteria
  • \> 18-years-old
  • MN Resident
  • Works in MN
  • Employed at the time of enrollment
  • Within 6 months of last day of work
  • Meets one of the following:
  • Provider work restrictions of unable to work for at least 4 weeks
  • Per healthcare team anticipated to be unable to work for at least 4 weeks
  • Employer's inability to accommodate current work restrictions
  • Meets one of the following:
  • Diagnosis of a work related or personal injury or illness that impacts employment
  • Invasive procedure (e.g., surgery) anticipated within the next 4-weeks that impacts employment
  • Documentation of work restrictions (i.e., written note/form documentation in electronic medical record prior to enrollment)
  • Exclusion Criteria
  • Legal representation/litigation at the time of enrollment related to a workers' compensation medical condition
  • Does not have the capacity to give appropriate informed consent
  • Employed by a RETAIN healthcare recipient or subrecipient with an existing return to work program for employees (i.e., Mayo Clinic employees)
  • Workers' compensation recipients that have a qualified rehabilitation consultant (QRC) or a disability case manager (DCM)
  • Pending application OR Receiving Social Security Disability Insurance (SSDI) or Supplemental Security Income (SSI)
  • Self-Employed

Exclusion

    Key Trial Info

    Start Date :

    December 23 2021

    Trial Type :

    INTERVENTIONAL

    Allocation :

    ESTIMATED

    End Date :

    May 1 2026

    Estimated Enrollment :

    5200 Patients enrolled

    Trial Details

    Trial ID

    NCT05216016

    Start Date

    December 23 2021

    End Date

    May 1 2026

    Last Update

    October 30 2025

    Active Locations (1)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (1 locations)

    1

    Mayo Clinic Rochester

    Rochester, Minnesota, United States, 55905